Trials / Unknown
UnknownNCT04932161
Efficacy of Titanium Granules in the Treatment of Periodontal Intrabony Defects
Comparative Efficacy of Titanium Granules Over Hydroxyapatite in the Treatment of Periodontal Intrabony Defects: A Clinico-radiographic Study
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 12 (estimated)
- Sponsor
- SVS Institute of Dental Sciences · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The ideal goal of the periodontal treatment is not only to prevent the progression of the disease, but also the regeneration and reconstruction of lost tissues. Many surgical techniques have been used to regenerate intrabony defects (IBD). Titanium stimulates activation of the complement system, surface binding of platelets, and platelet activation as reflected by increased levels of platelet-derived growth factor, which is a substantial promoter of bone growth. Hence we may speculate that using a bone substitute made of titanium may be positive from the perspective of bone formation in osseous defects.
Detailed description
Titanium granules consist of irregular porous granules of commercially pure titanium. The porous properties may lead to ingrowth of newly formed bone.The osseointegrating response to titanium may be the result of the potent activation of the intrinsic coagulation system and the subsequent release of growth factors from platelets.Therefore, the aim of this study is to compare the effect of titanium particles and hydroxyapatite on osseous regeneration in intrabony defects. After reflection of flap and degranulation, bone graft i.e., titanium particles (test group) or hydroxyapatite(control group) will be placed in the void created by the defect and sutures will be placed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Titanium Granules | After degranulation of the intrabony defect, titanium particles will be placed in the defect and will be sutured. |
| PROCEDURE | Hydroxyapatite | After degranulation of the intrabony defect, hydroxyapatite will be placed in the defect and will be sutured. |
Timeline
- Start date
- 2021-08-01
- Primary completion
- 2022-02-01
- Completion
- 2022-12-01
- First posted
- 2021-06-21
- Last updated
- 2021-06-21
Locations
1 site across 1 country: India
Source: ClinicalTrials.gov record NCT04932161. Inclusion in this directory is not an endorsement.